Our app transforms daily habits into a simple , motivating system that keeps you aligned when the scale is noisy
Novo Nordisk also recently started recruiting participants to the EVOKE trial program (phase III) expected to end in 2024, in which the effectiveness of oral semaglutide in the treatment of early Alzheimers disease will be assessed by measuring changes in clinical dementia rating, daily activity, mild cognitive impairment and mini-mental state examinations and other secondary outcome measures (NCT04777409, NCT04777396)
And somewhere along the way, people start believing that diet doesnt matter as much anymore
Link to full study here In April 2026, there was a pooled analysis of over 96,000 Patients specifically for adjudicated Non Arteritic Anterior Ischemic optic neuropathy in which 3/100k PYO on GLO1 RA experienced this complication compared to 6/100k in the placebo group
Went and had a vit b12 injection today , amina was professional and welcoming she made me comfortable and did her best to make sure it wasn't painful
They look similar on the surface